Neurology

Posdinemab, a monoclonal antibody that targets the mid-domain of Alzheimer disease-specific phosphorylated tau, is currently…

The revised protocol merges the 6-month symptomatic and 18-month disease-modifying studies into a single trial…

In a recent analysis, BrainCheck Access showed a high degree of alignment with the Montreal…

SGT-212 delivers full-length frataxin via MRI-guided intradentate nucleus infusion and intravenous administration to target mitochondrial…

The senior vice president of research at The ALS Association provided commentary on recently published…

The global Phase 3 trial aims to enroll ~150 patients with Dravet syndrome who have…

The professor in the department of clinical pharmacy and neurology at the University of Colorado…

The director of the Corinne Goldsmith Dickinson Center for MS at Mount Sinai talked about…

Lekha Rao, MD, an epileptologist at UCLA Health, discussed the challenges in diagnosing D/EE-SWAS, the…

Despite not meeting its primary and key secondary end points, an exploratory high dose cohort…